A Randomised Clinical Trial of Cognitive Activity for Older Adults with Mild Cognitive Impairment
轻度认知障碍老年人认知活动的随机临床试验
基本信息
- 批准号:nhmrc : 513772
- 负责人:
- 金额:$ 32.68万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Strategic Awards
- 财政年份:2008
- 资助国家:澳大利亚
- 起止时间:2008-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Australia’s population is ageing rapidly and so is the frequency of age-related disorders. Dementia is one of the most frequent mental health disorders of older people and one of the leading causes of years of life lost due to disability in Australia. Mild Cognitive Impairment (MCI) in old age is considered an important clinical state potentially predictive of future cognitive decline. There is increasing evidence that the onset of dementia can be delayed with targeting potentially modifiable risk factors. In older adults, frequent participation in mentally stimulating leisure activities has been associated with stronger cognitive (abilities such as memory) performances and reduced risk of dementia. Further, the rate of cognitive and functional decline can be influenced by cognitive intervention strategies, though few randomised control studies have explored these findings with individuals who have a diagnosis of MCI. The primary focus of this research is to determine whether a structured program of cognitive activity (CA) can delay progression of cognitive decline amongst older adults with MCI. 160 older adults will be randomised (by chance, like the flip of a coin) to either a 10 week CA intervention with a focus on cognitive training and rehabilitation techniques or a 10 week control educational intervention providing information on aging and retirement. Their cognitive performance, quality of life and functional level will be monitored during follow-up. The proposed study will improve the understanding of possible modifying factors of cognition and highlight the potential of intervention in an older age population. The obtained results will have implications for policy recommendations regarding health care resources and facilitate changes in the approach and management of individuals with MCI.
澳大利亚的人口正在迅速老龄化,与年龄相关的疾病的频率也在迅速上升。痴呆症是老年人最常见的精神健康障碍之一,也是澳大利亚因残疾而损失寿命的主要原因之一。老年轻度认知障碍(MCI)被认为是一种重要的临床状态,可能预示着未来的认知能力下降。越来越多的证据表明,通过瞄准潜在的可改变的危险因素,可以推迟痴呆症的发生。在老年人中,经常参加刺激大脑的休闲活动与更强的认知能力(如记忆)表现和降低患痴呆症的风险有关。此外,认知干预策略可能会影响认知和功能衰退的速度,尽管很少有随机对照研究在确诊为MCI的个体中探索这些发现。这项研究的主要焦点是确定结构化的认知活动计划(CA)是否可以延缓患有MCI的老年人认知能力下降的进展。160名老年人将被随机(就像掷硬币一样),接受10周的CA干预,重点是认知训练和康复技术,或者10周的对照教育干预,提供关于衰老和退休的信息。在随访期间将监测他们的认知表现、生活质量和功能水平。这项拟议的研究将提高对可能的认知调节因素的理解,并突出在老年人口中进行干预的潜力。所获得的结果将对有关卫生保健资源的政策建议产生影响,并有助于改变对MCI患者的方法和管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ms Mandy Vidovich其他文献
Ms Mandy Vidovich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Phase 1 Randomised Clinical Trial of the First-in-Class KMO inhibitor KNS366
首创KMO抑制剂KNS366的1期随机临床试验
- 批准号:
10017279 - 财政年份:2022
- 资助金额:
$ 32.68万 - 项目类别:
Collaborative R&D
Steroid-Reducing Options for ReLapsING PMR (STERLING-PMR): a pragmatic, randomised trial to compare the clinical and cost-effectiveness of adding immunosuppression to steroid-tapering treatment for patients with relapsing PMR, versus steroid-tapering
ReLapsING PMR 的类固醇减少方案 (STERLING-PMR):一项务实的随机试验,旨在比较在复发性 PMR 患者的类固醇逐渐减少治疗中添加免疫抑制与类固醇逐渐减少的临床和成本效益
- 批准号:
nhmrc : 2006408 - 财政年份:2022
- 资助金额:
$ 32.68万 - 项目类别:
International Collaborations
A phase III multicentre blinded randomised controlled clinical non-inferiority trial of cryopreserved platelets vs. conventional liquid-stored platelets for the management of post-surgical bleeding.
一项关于冷冻保存血小板与传统液体储存血小板治疗术后出血的 III 期多中心盲法随机对照临床非劣效性试验。
- 批准号:
nhmrc : GNT1156641 - 财政年份:2019
- 资助金额:
$ 32.68万 - 项目类别:
Project Grants
MICA: Phase IIb randomised clinical trial repurposing ATRA as a stromal targeting agent in a novel drug combination for pancreatic cancer (STAR-PAC2).
MICA:IIb 期随机临床试验,将 ATRA 重新用作胰腺癌新型药物组合 (STAR-PAC2) 中的基质靶向剂。
- 批准号:
MR/S036601/1 - 财政年份:2019
- 资助金额:
$ 32.68万 - 项目类别:
Research Grant
Strengthening exercise or combined strengthening and aerobic exercise for hip osteoarthritis: a randomised clinical trial
强化运动或结合强化运动和有氧运动治疗髋骨关节炎:一项随机临床试验
- 批准号:
nhmrc : GNT1159045 - 财政年份:2019
- 资助金额:
$ 32.68万 - 项目类别:
Project Grants
Diagnostic and prognostic value of coronary artery flow and morphology in a multicentre randomised trial of computed tomography versus invasive angiography: clinical radiomics analysis
计算机断层扫描与侵入性血管造影多中心随机试验中冠状动脉血流和形态的诊断和预后价值:临床放射组学分析
- 批准号:
428223139 - 财政年份:2019
- 资助金额:
$ 32.68万 - 项目类别:
Priority Programmes
Can esomeprazole improve outcomes in women at high risk of pre-eclampsia? A Phase II placebo-controlled randomised, multi-centre clinical trial.
埃索美拉唑能否改善先兆子痫高危女性的预后?
- 批准号:
nhmrc : 1145585 - 财政年份:2018
- 资助金额:
$ 32.68万 - 项目类别:
Project Grants
Clinical utility and cost-effectiveness of genome sequencing for refractory epilepsy in children and adults: a multicentre randomised controlled trial
儿童和成人难治性癫痫基因组测序的临床效用和成本效益:多中心随机对照试验
- 批准号:
nhmrc : GNT1143934 - 财政年份:2018
- 资助金额:
$ 32.68万 - 项目类别:
Project Grants
Clinical utility and cost-effectiveness of genome sequencing for refractory epilepsy in children and adults: a multicentre randomised controlled trial
儿童和成人难治性癫痫基因组测序的临床效用和成本效益:多中心随机对照试验
- 批准号:
nhmrc : 1143934 - 财政年份:2018
- 资助金额:
$ 32.68万 - 项目类别:
Project Grants
Can esomeprazole improve outcomes in women at high risk of pre-eclampsia? A Phase II placebo-controlled randomised, multi-centre clinical trial.
埃索美拉唑能否改善先兆子痫高危女性的预后?
- 批准号:
nhmrc : GNT1145585 - 财政年份:2018
- 资助金额:
$ 32.68万 - 项目类别:
Project Grants














{{item.name}}会员




